In contrast, APE1 expression was significantly modulated in the groups (JT test, p = 0.032), with the lowest levels detected in the asymptomatic group and the highest levels in the symptomatic group with anosmia and/or ageusia. This evidence concerns the gene APEX1 and Kallmann syndrome.